Tharimmune, Inc. announced on August 5, 2025, the appointment of Nancy Davis to its Board of Directors. Ms. Davis is a globally recognized philanthropist and the visionary founder of the Race to Erase MS and Cure Addiction Now foundations.
Ms. Davis brings an unparalleled fusion of deep-seated patient advocacy, strategic fundraising, and a profound personal commitment to accelerating scientific discovery in areas of critical unmet medical need. Her experience is expected to significantly benefit Tharimmune's strategic direction.
This appointment strengthens the company's board with expertise relevant to patient-centered innovation and capital generation. It aligns with Tharimmune's mission to develop therapeutic candidates for inflammation, immunology, and critical unmet medical needs.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.